
Sorrento Therapeutics
North America, California, United States, San Diego
Description
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Investor Profile
Sorrento Therapeutics has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 40% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Private Equity, Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Biotechnology, Therapeutics.
Stage Focus
- Series Unknown (20%)
- Private Equity (20%)
- Post Ipo Equity (20%)
- Series B (20%)
- Seed (20%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Biotechnology
- Therapeutics
- Wellness
- Life Science
- Health Diagnostics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.